Prosecution Insights
Last updated: April 19, 2026
Application No. 18/241,187

STENT WITH IMPROVED STICKINESS OF MEMBRANE

Non-Final OA §103
Filed
Aug 31, 2023
Examiner
PRONE, CHRISTOPHER D
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Sewoon Medical Co. Ltd.
OA Round
1 (Non-Final)
65%
Grant Probability
Moderate
1-2
OA Rounds
4y 6m
To Grant
84%
With Interview

Examiner Intelligence

Grants 65% of resolved cases
65%
Career Allow Rate
515 granted / 797 resolved
-5.4% vs TC avg
Strong +19% interview lift
Without
With
+19.4%
Interview Lift
resolved cases with interview
Typical timeline
4y 6m
Avg Prosecution
58 currently pending
Career history
855
Total Applications
across all art units

Statute-Specific Performance

§101
2.4%
-37.6% vs TC avg
§103
42.3%
+2.3% vs TC avg
§102
23.9%
-16.1% vs TC avg
§112
29.0%
-11.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 797 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority This application claims priority from foreign application KR10/2021-002392, filed 03/03/2021. Status of Claims Claims 1-8 are pending. Information Disclosure Statement The Information Disclosure Statement filed on 08/31/2023 has been considered by the examiner. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-8 are rejected under 35 U.S.C. 103 as being unpatentable over Coleman et al (Coleman) US 2010/0124563 A1 in view of Chaikof et al (Chaikof) USPN 5,741,325. 1. Coleman discloses a stent [0160] with an improved stickiness of a membrane (the stickiness is improved by the properties of the micro rough surfaces, which is Coleman disclosed his invention includes, see Abstract), comprising: a membrane portion provided in/covering the stent ([0134] discloses the membrane includes the porous cell scaffold and [0160] discloses the membrane is within the stent); and a micro-rough surface formed on all or at least a part of the membrane portion ([0101] discloses the cell scaffold can include the surface roughness). However, Coleman does not disclose the specific shape or nature of the stent. Chaikof teaches the use of a stent (Figures 1-2) comprising a body portion including a hollow cylindrical shape (Figures 1-2) wherein wires are woven to form a mesh structure (5:63-66) in the same field of endeavor for the purpose of providing a flexible self expandible stent that adapts to the shape of the implant site. It would have been obvious to one having ordinary skill in the art at the time the invention was made to provide the stent of Coleman with the shape made by woven strands of Chaikof in order to provide a flexible self expandible stent that adapts to the shape of the implant site. 2. Coleman discloses the micro-rough surface is formed by a plurality of irregular embossing protrusions that are disorderly formed [0101]. 3. Coleman discloses a first surface roughness of the micro-rough surface is in a range of tens to hundreds of micrometers in size [0101]. In regards to claims 4-7 the claimed method of forming the membrane on a jig, the forming of the first surface on the jig, and the forming of the second surface on the jig amounts to a product by process. Whether a product is patentable depends on whether it is known in the art or it is obvious, and is not governed by whether the process by which it is made is patentable. Product by process claims are not construed as being limited to the product formed by the specific process recited. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process (see MPEP 2113). In this case the membrane and surface roughnesses are fully capable of being formed on a jig with a corresponding surface roughness, which is axially rotated and a polymer material is uniformly and sand blasted, etched, and/or cured. These are commonly used tools and procedures within the stent/graft manufacturing art. 8. Coleman discloses the micro-rough surface reduces a stickiness of an inner face of the membrane portion (since Coleman discloses the same shapes and dimensions for the micro-rough surface as the current invention it will inherently reduce the stickiness of the inner face of the membrane as much as the applicant’s invention). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHRISTOPHER D PRONE whose telephone number is (571)272-6085. The examiner can normally be reached Monday-Friday 10 am - 6 pm (HST). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Melanie R Tyson can be reached at (571)272-9062. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. CHRISTOPHER D. PRONE Primary Examiner Art Unit 3774 /Christopher D. Prone/Primary Examiner, Art Unit 3774
Read full office action

Prosecution Timeline

Aug 31, 2023
Application Filed
Jan 23, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594175
CORE ASSEMBLY FOR MEDICAL DEVICE DELIVERY SYSTEMS
2y 5m to grant Granted Apr 07, 2026
Patent 12594153
GENDER-SPECIFIC MESH IMPLANT WITH BARRIER FOR INGUINAL HERNIA REPAIR
2y 5m to grant Granted Apr 07, 2026
Patent 12588985
COMPLIANT BIOLOGICAL SCAFFOLD
2y 5m to grant Granted Mar 31, 2026
Patent 12575934
PROSTHETIC IMPLANTS INCLUDING A FRAME FOR FIXATION TO BONE AND RELATED METHODS
2y 5m to grant Granted Mar 17, 2026
Patent 12564492
Retrievable Self-Expanding Non-Thrombogenic Low-Profile Percutaneous Atrioventricular Valve Prosthesis
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
65%
Grant Probability
84%
With Interview (+19.4%)
4y 6m
Median Time to Grant
Low
PTA Risk
Based on 797 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month